| Learning about the effectiveness of lung cancer screening in real-world target populations |
Sarah Robertson |
Dartmouth College |
PLCO |
Dec 22, 2025 |
PLCO-2005 |
| Evaluating Multi-trait PRS Methods on Cancer Phenotypes in PLCO |
Phillip Kraft |
National Cancer Institute |
PLCO |
Dec 16, 2025 |
PLCO-2004 |
| Developing Contextualized Cancer Risk Models: Integrating Polygenic Risk Scores with Environmental, Geospatial, and Social Determinants of Health Data |
Phillip Kraft |
National Cancer Institute |
PLCO |
Dec 16, 2025 |
PLCO-2003 |
| Enhancing Pathology Foundation Models for Cancer Prognosis through Integration of PLCO H&E Stained Pathology Images |
Siyi Tang |
Artera Inc. |
PLCO |
Dec 10, 2025 |
PLCOI-2002 |
| Comparative Analysis of Military Veteran Cancer Biomarkers Using the PLCO Dataset as a Civilian Control Cohort |
Chelsey Simoni |
HunterSeven Foundation |
PLCO |
Dec 10, 2025 |
PLCO-1989 |
| Identifying Proteomics Associated with Diet |
Steven Moore |
National Cancer Institute |
PLCO |
Dec 1, 2025 |
PLCO-2001 |
| Geographical Variation in Estrogen Levels |
Steven Moore |
National Cancer Institute |
PLCO |
Dec 1, 2025 |
PLCO-1999 |
| Can we predict early biochemical response after chemotherapy in Stage IV colon cancer patients using baseline clinical and treatment features |
Dr. Johnson P. Thomas |
Oklahoma State University |
PLCO |
Nov 24, 2025 |
PLCO-1994 |
| Validation of multimodal deep learning models for the prediction of risks of lung cancer and adverse cardiovascular events using chest radiographs and clinical data |
EUIJIN HWANG |
Seoul National University Hospital |
PLCO |
Nov 24, 2025 |
PLCOI-1958 |
| Synthetic Clinical Trial based on Polygenic Risk Scores |
Mitchell Machiela |
National Cancer Institute |
PLCO |
Nov 24, 2025 |
PLCO-1998 |
| Building Digital Twin Framework for Personalization of Prostate Cancer Management in Kidney Transplant Patients |
Naoru Koizumi |
George Mason University |
PLCO |
Nov 17, 2025 |
PLCO-1997 |
| Competing risks analysis of multiple cancers with application to vitamin D in PLCO |
Yei Eun Shin |
Seoul National University |
PLCO |
Nov 17, 2025 |
PLCO-1979 |
| AI Risk Prediction for Breast Cancer |
Anne Martel |
Sunnybrook Research Institute |
PLCO |
Nov 13, 2025 |
PLCOI-1924 |
| Predictive analytics with automated machine learning applied to ovarian cancer image data |
Jacob Levman |
St. Francis Xavier University |
PLCO |
Nov 13, 2025 |
PLCOI-1992 |
| Investigating Thymic Function in Human Papillomavirus (HPV)-Related Cancer Risk and Survival |
Eric Engels |
National Cancer Institute, National Institutes of Health |
PLCO |
Sep 29, 2025 |
PLCO-1991 |
| Predictive analytics with machine learning for ovarian cancer |
Jacob Levman |
St. Francis Xavier University |
PLCO |
Sep 22, 2025 |
PLCO-1990 |
| AI-Driven Analyses of Morphological and Phenotypic Profiles Across Cancers |
JUNHAN ZHAO |
The University of Chicago |
PLCO |
Sep 22, 2025 |
PLCOI-1985 |
| Genetic Associations Between High-Risk Pulmonary Nodules and Risk of Lung Adenocarcinoma and Squamous Cell Carcinoma |
Douglas Easton |
University of Cambridge |
PLCO |
Sep 22, 2025 |
PLCO-1987 |
| Development and Validation of Cancer Risk Prediction Models Using Publicly Available Cohort Data |
Luke Stetson |
PreOncology |
PLCO |
Sep 22, 2025 |
PLCO-1986 |
| Geographical and socioeconomic disparities across site-specific and pan-cancer risk factors |
Mikko Myrskylä |
Max Planck Institute for Demographic Research |
PLCO |
Sep 22, 2025 |
PLCO-1983 |
